Just in Time for Summer Sandal Season: Valeant’s Jublia® Approved for Onychomycosis
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
The US Food and Drug Administration (FDA) has approved Jublia® (efinaconazole 10% topical solution) for the treatment of onychomycosis of the toenails.
Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.